First stereotactic radiotherapy system designed for breast cancer receives FDA clearance

(University of Maryland School of Medicine) The GammaPod ™ -- a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer -- has received 510(k) clearance from the US Food and Drug Administration (FDA), paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.